BiomX PHGE
NYSE PHGE
$1.67 +0.12 (+7.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

BiomX (PHGE) Price to Earnings (2019 - 2026)

BiomX's (PHGE) quarterly Price to Earnings came in at 0.94 in Q2 2026, down 52.38% year-over-year from 1.97 in Q2 2025, and up 84.59% quarter-over-quarter from 0.51 in Q1 2026.

Analysis

BiomX (PHGE) Price to Earnings (2019 - 2026) Analysis & Trends

BiomX has disclosed Price to Earnings across 8 years of filings, most recently posting 0.94 for Q2 2026.

  • In Q2 2026, Price to Earnings fell 52.38% year-over-year to 0.94; the TTM figure through Jun 2026 stood at 0.14 (up 114.09% YoY), while the FY2025 annual figure was 0.08, up 116.63% from the prior year.
  • Price to Earnings came in at 0.94 for Q2 2026 at BiomX, up from 0.51 in the prior quarter.
  • In the past five years, Price to Earnings ranged from a high of 4.39 in Q2 2023 to a low of 24.57 in Q2 2024.
  • Average Price to Earnings over 5 years is 1.91, with a median of 0.47 recorded in 2023.
  • Year-over-year, Price to Earnings soared 331.78% in 2023 and tumbled 659.06% in 2024.
  • Over 5 years, Price to Earnings stood at 2.34 in 2022, then surged by 80.05% to 0.47 in 2023, then gained by 10.41% to 0.42 in 2024, then dropped by 24.12% to 0.52 in 2025, then jumped by 280.45% to 0.94 in 2026.
  • Per Business Quant data, the three most recent Price to Earnings figures were 0.94 in Q2 2026, 0.51 in Q1 2026, and 0.52 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BiomX 1.55 Mn 7.73 Mn 97,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.94
Mar 31, 2026 0.51
Dec 31, 2025 -0.52
Sep 30, 2025 1.54
Jun 30, 2025 1.97
Mar 31, 2025 1.81
Dec 31, 2024 -0.42
Sep 30, 2024 -3.66
Jun 30, 2024 -24.57
Dec 31, 2023 -0.47
Sep 30, 2023 3.48
Jun 30, 2023 4.39
Mar 31, 2023 -3.75
Dec 31, 2022 -2.34
Sep 30, 2022 -1.50
Jun 30, 2022 -2.90
Mar 31, 2022 -7.03
Dec 31, 2021 -4.55
Sep 30, 2021 -8.60
Jun 30, 2021 -18.26